ConductScience.org, home

Paper35844014

The rate of venous thromboembolism after knee bone marrow concentrate procedures: should we anticoagulate?

Centeno CJ and 4 others. Int Orthop, 2022. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. The rate of venous thromboembolism after knee bone marrow concentrate procedures: should we anticoagulate? Papers, record 35844014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35844014

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The rate of venous thromboembolism after knee bone marrow concentrate procedures: should we anticoagulate?
PubMed
Journal
Int Orthop
PubMed
Year
2022
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Observational Study
PubMed
Citations, by iCite
0
iCite
Relative citation ratio, by iCite
0
iCite
Revised in PubMed
2025-07-28
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Centeno CJChristopher J
2Money BTBrandon T
3Dodson EEhrenhttps://orcid.org/0000-0002-5808-6068
4Stemper IIan
5Steinmetz NJNeven J

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bone MarrowMajor topic
Osteoarthritis, KneeMajor topic
Venous ThromboembolismMajor topic
Anticoagulants
Humans
Retrospective Studies

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT03011398A Clinical Registry of Orthobiologics ProceduresDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128990575A systematic review of the concept and clinical applications of bone marrow aspirate concentrate in tendon pathology.SICOT J2017https://conductscience.org/library/papers/28990575PubMed
230545387A specific protocol of autologous bone marrow concentrate and platelet products versus exercise therapy for symptomatic knee osteoarthritis: a randomized controlled trial with 2 year follow-up.J Transl Med2018https://conductscience.org/library/papers/30545387PubMed
332617651
Subchondral bone or intra-articular injection of bone marrow concentrate mesenchymal stem cells in bilateral knee osteoarthritis: what better postpone knee arthroplasty at fifteen years? A randomized study.
Int Orthop2021https://conductscience.org/library/papers/32617651PubMed
431328447Functional Outcomes Following Microfragmented Adipose Tissue Versus Bone Marrow Aspirate Concentrate Injections for Symptomatic Knee Osteoarthritis.Stem Cells Transl Med2019https://conductscience.org/library/papers/31328447PubMed
526798765Concentrated Bone Marrow Aspirate for the Treatment of Chondral Injuries and Osteoarthritis of the Knee: A Systematic Review of Outcomes.Orthop J Sports Med2016https://conductscience.org/library/papers/26798765PubMed
627026621A multi-center analysis of adverse events among two thousand, three hundred and seventy two adult patients undergoing adult autologous stem cell therapy for orthopaedic conditions.Int Orthop2016https://conductscience.org/library/papers/27026621PubMed
724352775Cancer risk is not increased in patients treated for orthopaedic diseases with autologous bone marrow cell concentrate.J Bone Joint Surg Am2013https://conductscience.org/library/papers/24352775PubMed
823973124The epidemiology and impact of pain in osteoarthritis.Osteoarthritis Cartilage2013https://conductscience.org/library/papers/23973124PubMed
917403800Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030.J Bone Joint Surg Am2007https://conductscience.org/library/papers/17403800PubMed
1028801208Projected increase in total knee arthroplasty in the United States - an alternative projection model.Osteoarthritis Cartilage2017https://conductscience.org/library/papers/28801208PubMed
1130180053Projected Volume of Primary Total Joint Arthroplasty in the U.S., 2014 to 2030.J Bone Joint Surg Am2018https://conductscience.org/library/papers/30180053PubMed
1233789702Serious adverse events and 30-day hospital readmission rate following elective total knee arthroplasty: a systematic review and meta-analysis.J Orthop Surg Res2021https://conductscience.org/library/papers/33789702PubMed
132785998Deep vein thrombosis after elective knee surgery. An incidence study in 312 patients.J Bone Joint Surg Br1989https://conductscience.org/library/papers/2785998PubMed
1428634095Comparative Effectiveness and Safety of Drug Prophylaxis for Prevention of Venous Thromboembolism After Total Knee Arthroplasty.J Arthroplasty2017https://conductscience.org/library/papers/28634095PubMed
1530347089Association of Aspirin With Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty Compared With Other Anticoagulants: A Noninferiority Analysis.JAMA Surg2019https://conductscience.org/library/papers/30347089PubMed
1622253396Symptomatic in-hospital deep vein thrombosis and pulmonary embolism following hip and knee arthroplasty among patients receiving recommended prophylaxis: a systematic review.JAMA2012https://conductscience.org/library/papers/22253396PubMed
177631356Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses.Stroke1995https://conductscience.org/library/papers/7631356PubMed
1826028142Utilization rates of knee-arthroplasty in OECD countries.Osteoarthritis Cartilage2015https://conductscience.org/library/papers/26028142PubMed
1923845765Variation of Medicare payments for total knee arthroplasty.J Arthroplasty2013https://conductscience.org/library/papers/23845765PubMed
2033422392Projected Economic Burden of Periprosthetic Joint Infection of the Hip and Knee in the United States.J Arthroplasty2021https://conductscience.org/library/papers/33422392PubMed

See all 26 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35844014

GET https://conductscience.org/api/papers/v1/35844014/references?page=2